The transaction involved Eugene ENT acquiring 30.95% from KEPCO KDN and the Korea Racing Authority. Auditors questioned sale conditions that excluded certain large companies.

The matter was referred to the Corruption Investigation Office for High-ranking Officials. The audit findings do not constitute a criminal conviction.